CEO of drugmaker Bristol Myers sees 'real need' for policy reform on prescription pricing

Bristol-Myers Squibb CEO Giovanni Caforio tells Jim Cramer that his company believes the affordability of prescription drugs is a problem. "Medicines are important only when they reach patients," he says.
Mon, Nov 25 20196:49 PM EST